Sulfated oxysterol, 25HC3S, is a potent regulator of lipid metabolism in human hepatocytes |
| |
Authors: | Ren Shunlin Li Xiaobo Rodriguez-Agudo Daniel Gil Gregorio Hylemon Phillip Pandak William M |
| |
Affiliation: | Department of Medicine, Veterans Affairs McGuire Medical Center/Virginia Commonwealth University, Richmond, VA 23249, USA. sren@vcu.edu |
| |
Abstract: | Recently, a novel oxysterol, 5-cholesten-3beta, 25-diol 3-sulfate (25HC3S) was identified in primary rat hepatocytes following overexpression of the cholesterol transport protein, StarD1. This oxysterol was also detected in human liver nuclei. In the present study, 25HC3S was chemically synthesized. Addition of 25HC3S (6 microM) to human hepatocytes markedly inhibited cholesterol biosynthesis. Quantitative RT-PCR and Western blot analysis showed that 25HC3S markedly decreased HMG-CoA reductase mRNA and protein levels. Coincidently, 25HC3S inhibited the activation of sterol regulatory element binding proteins (SREBPs), suggesting that inhibition of cholesterol biosynthesis occurred via blocking SREBP-1 activation, and subsequently by inhibiting the expression of HMG CoA reductase. 25HC3S also decreased SREBP-1 mRNA levels and inhibited the expression of target genes encoding acetyl CoA carboxylase-1 (ACC-1) and fatty acid synthase (FAS). In contrast, 25-hydroxycholesterol increased SREBP1 and FAS mRNA levels in primary human hepatocytes. The results imply that 25HC3S is a potent regulator of SREBP mediated lipid metabolism. |
| |
Keywords: | Cholesterol and lipids metabolism HMG-CoA reductase Bile acid synthesis Acetyl CoA carboxylase-1 Fatty acid synthase SREBPs Mitochondria 5-Cholesten-3β 25-Diol 3-sulfate |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|